CDH1 and cancer: Neutralizing FadA abrogated the tumor-promoting activities of F. nucleatum in a murine xenograft cancer model [4], demonstrating the potential of targeting bacterial interactions with E-cadherin as a novel strategy in mitigating cancer progression.